Friess Associates LLC Coherus Bio Sciences, Inc. Transaction History

Friess Associates LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$16.56 - $18.94 $1.62 Million - $1.85 Million	-97,932 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$17.41 - $19.89 $91,715 - $104,780	-5,268 Reduced 5.1%	97,932 $1.8 Million
Q2 2020 Aug 14, 2020	SELL	$14.43 - $19.16 $2.7 Million - $3.59 Million	-187,380 Reduced 64.48%	103,200 $1.84 Million
Q1 2020 May 15, 2020	BUY	$11.67 - $22.53 $3.39 Million - $6.55 Million	290,580 New	290,580 $4.71 Million

135

78M

40.7K

50.1K

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $108M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

Get notified when there are updates to the investment portfolio of Friess Associates LLC, based on Form 13F filings with the SEC.

Stay updated on Friess Associates LLC with notifications on news.